TLIS

Talis Biomedical Corporation Common Stock
TLIS

Overview Fund Activity
Delisted

TLIS was delisted on the 30th of August, 2024.

Back to rankings

22 hedge funds and large institutions have $5.76M invested in Talis Biomedical Corporation Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.

Holders
22
Holders Change
-5
Holders Change %
-18.52%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$80K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$21K
3
Morgan Stanley
3
Morgan Stanley
New York
$29.8K
4
Wells Fargo
4
Wells Fargo
California
$82

Top Sellers

1
ACH
1
ArrowMark Colorado Holdings
Colorado
$235K
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
Jane Street
3
Jane Street
New York
$0
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$231K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
– – -40 Closed
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$0 123 – –
TRCT
29
Tower Research Capital (TRC)
New York
$0 527 +527 New
1
2